Amlodipin Bluefish

Quick links to important sections

Amlodipin Bluefish

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Amlodipin Bluefish

Property Description
Active ingredient Amlodipine (as Amlodipine besilate)
Form Oral tablet
Pharmacological class Calcium Channel Blocker (CCB)
General purpose Reducing circulatory resistance
Origin Synthetic substance

The Core Identity: What Type of Medicine is Amlodipin Bluefish?

Amlodipin Bluefish is a synthetic, single-component prescription medicine that utilizes the active substance Amlodipine (formulated as Amlodipine besilate). It is fundamentally classified as a Calcium Channel Blocker (CCB), belonging specifically to the long-acting dihydropyridine class. The drug's classification and active component are defined by its pharmacological properties.

This classification means the medication’s primary action is to inhibit the flow of calcium ions into certain muscle cells, particularly those in the walls of the blood vessels. The active ingredient, Amlodipine, is clinically recognized for its sustained duration of effect, which supports once-daily administration for consistent therapeutic coverage.

Form and Composition: How is Amlodipin Bluefish Supplied?

Amlodipin Bluefish is typically supplied as an oral tablet intended for systemic administration (swallowed by mouth). As a monotherapy preparation manufactured by Bluefish Pharmaceuticals, the tablet’s composition is based on the Amlodipine besilate salt combined with a stable matrix of solid pharmaceutical excipients.

These inactive components, such as fillers and binders, are necessary to create the rigid tablet structure, ensuring product stability and accurate dosing. While Amlodipine is the International Nonproprietary Name (INN) for the active substance, Amlodipin Bluefish is distinguished by its specific manufacturer and its positioning as a dependable delivery system.

General Purpose: What Does Amlodipine Help to Achieve?

The general purpose of Amlodipine is to reduce the overall workload on the cardiovascular system by promoting the relaxation and widening of the arterial blood vessels. This effect, known as vasodilation, lowers the circulating resistance against which the heart must pump blood.

Amlodipine functions as a peripheral vasodilator, which aids in stabilizing circulatory health. By easing this resistance, Amlodipine plays a foundational role in achieving and maintaining controlled blood pressure and minimizing chronic stress on the heart muscle.

Regulatory References

  1. NIH DailyMed: Amlodipine Besylate Tablet

What side effects are possible with Amlodipin Bluefish?

The official safety profile of Amlodipin (Amlodipine) is structured by government regulatory agencies based on the frequency of observed adverse reactions and the System-Organ-Class (SOC) affected, as documented in clinical trials and post-marketing experience.

Adverse Reaction Scope

Classification Examples of Documented Reactions
Very Common (1/10) Oedema (Swelling)
Common (1/100) Headache, dizziness, somnolence, fatigue, nausea, abdominal pain, flushing, palpitations
Very Rare (< 1/10,000) Pancreatitis, hepatitis, jaundice, gingival hyperplasia, myocardial infarction, and serious skin reactions (e.g., Angioedema)

Safety Considerations and Restrictions

Regulatory documents highlight that adverse reactions like headache and somnolence are officially noted as being more common at the beginning of treatment. The most frequently reported adverse reaction, oedema, is explicitly stated to be dose-related.

Serious adverse reactions documented in regulatory warnings include the potential for worsening angina or acute myocardial infarction upon starting therapy or increasing the dose, and the possibility of symptomatic hypotension, particularly in patients with severe aortic stenosis. Contraindications listed in official labeling include pre-existing severe hypotension and shock.

For specific populations, safety considerations are defined: clearance is reduced in older adults and in patients with hepatic impairment. Official guidelines recommend considering the lowest starting dose for these patient groups. Additionally, caution is noted for patients with severe heart failure (NYHA Class III and IV) due to a documented higher incidence of pulmonary oedema compared to placebo in one study.

This framework of frequency, system grouping, and warnings establishes a factual, descriptive basis for the drug's safety profile, as mandated by regulatory bodies.

Overdose and Emergency Response

Overdose and When to Seek Help

Amlodipin Bluefish overdose is documented in regulatory sources to result primarily from excessive peripheral vasodilation, leading to profound and prolonged systemic hypotension. This severe drop in blood pressure may be accompanied by reflex tachycardia.

Officially Documented Manifestations and Risks

Category Official Regulatory Statement
Primary Clinical Sign Profound and prolonged systemic hypotension.
Severe Outcome Overdose is associated with the risk of shock and death.
Help-Seeking Action Immediate medical attention and institution of active monitoring are required.

Management and Monitoring Requirements

Overdose management is symptomatic and supportive, as no specific antidote is known. The official guidance dictates that measures must be taken to restore cardiovascular stability, which includes the use of intravenous fluids and, if hypotension is refractory, vasopressor administration and intravenous calcium gluconate.

Due to the substance's long terminal elimination half-life of 30 to 50 hours, extended clinical monitoring is necessary. Furthermore, regulatory documents state that Amlodipine is not dialyzable. Specific considerations apply to patients with impaired hepatic function, where the elimination half-life may be further prolonged.

Therapeutic Uses of Amlodipin Bluefish

What Amlodipin Bluefish Treats: Main Uses and Benefits

The primary therapeutic applications of Amlodipin Bluefish are used in situations involving symptoms related to systemic imbalance and cardiovascular stress. The medication is commonly used to treat high blood pressure (hypertension) and certain types of angina (chest pain) and coronary artery disease.


Therapeutic Support for Cardiovascular Symptoms

Amlodipin Bluefish is commonly used in the management of elevated blood pressure in adults and is considered relevant for use in pediatric patients aged 6 to 17. The core conditions it helps manage are hypertension, chronic stable angina, and vasospastic angina. By addressing symptom clusters related to heightened physiological activity, this medication may contribute to the long-term benefit of easing strain on the cardiovascular system. It assists with maintaining functional stability, which may help patients cope more steadily with symptom fluctuations.

It is relevant for easing symptoms that are linked to organ-specific functional stress. Amlodipine helps address symptom clusters that may become intense or disruptive, contributing to improved comfort during periods of heightened symptoms.


QuickFact Block

Quick Fact: Relief for High Blood Pressure and Angina
Primary Domain Cardiovascular conditions (Hypertension, Angina).
Symptom Category Symptoms related to systemic imbalance and organ-specific functional stress.
Typical Context Relevant for long-term supportive management.
Key Benefit Contributes to easing the overall symptom load and supports patients during episodes of heightened discomfort.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Amlodipin Bluefish eligibility is determined by official constraints outlined in regulatory documents, defining specific patient populations for whom use is allowed, restricted, or prohibited.

Contraindicated Populations

Use of this medicine is formally contraindicated in patients with:

  • Known hypersensitivity to amlodipine, its drug class (dihydropyridines), or any excipients.
  • Severe hypotension (very low blood pressure) or a state of shock, including cardiogenic shock.
  • Obstruction of the left ventricular outflow tract (e.g., severe aortic stenosis).
  • Haemodynamically unstable heart failure following an acute heart attack.

Age and Comorbidity Restrictions

Population Category Eligibility Status (Regulatory Labeling)
Adults Approved for both hypertension and angina.
Children (6 to 17 years) Approved for hypertension only; use is not established for angina.
Children (under 6 years) Use is not recommended as safety and efficacy have not been established.
Hepatic Impairment Requires caution; a lower initial dose is recommended due to drug metabolism.
Renal Impairment No dose adjustment is typically required.
Pregnancy/Lactation Not recommended unless the potential benefit justifies the risk, and no safer alternative is available.

What should I know about interactions with other medicines?

The official interaction profile for Amlodipine is defined by its involvement in the CYP3A4 metabolic pathway. Co-administration with strong or moderate CYP3A4 inhibitors such as Diltiazem, Ketoconazole, or Itraconazole is formally documented to significantly increase Amlodipine systemic exposure (AUC). Conversely, strong CYP3A4 inducers, including Rifampicin and the herbal product St. John's Wort (Hypericum perforatum), are noted in regulatory information to cause Amlodipine concentration to vary or decrease.

Amlodipine also alters the exposure of specific co-administered medicines. The most significant official finding is the 77% increase in Simvastatin exposure (AUC). This pharmacokinetic outcome necessitates a strict regulatory restriction: the daily dose of Simvastatin must not exceed 20 mg when co-administered. Amlodipine is also documented to increase the exposure of mTOR inhibitors and Cyclosporine.

A pharmacodynamic interaction results in an additive hypotensive effect when Amlodipine is co-administered with other antihypertensive agents or Ethanol (Alcohol). Furthermore, the consumption of Grapefruit Juice is documented to increase Amlodipine plasma concentration. Regulatory documents note that the clinical expression of these pharmacokinetic effects may be more pronounced in the elderly and in patients with hepatic impairment, who exhibit a documented decrease in clearance.

Mechanism of Action

Mechanism: Binding to L-Type Calcium Channels

Amlodipin Bluefish is a dihydropyridine calcium channel blocker. The compound functions by selectively binding to L-type voltage-dependent calcium channels located primarily on vascular smooth muscle cells and, to a lesser extent, on cardiac muscle cells. This binding inhibits the transmembrane influx of extracellular calcium ions (Ca^2+) into the cell cytoplasm.

Intracellular Cascade: Excitation-Contraction Decoupling

The inhibition of calcium influx directly prevents the excitation-contraction coupling process in muscle cells. This action leads to a sustained decrease in the intracellular concentration of free calcium ions. Lower Ca^2+ availability limits the activation of the contractile machinery within the smooth muscle.

Physiological Effect: Smooth Muscle Relaxation

The subsequent relaxation of the vascular smooth muscle results in peripheral vasodilation. This physiological consequence is responsible for the overall reduction in peripheral vascular resistance (afterload) and an increase in coronary blood flow.

Dosage and Administration Information

Official Administration Guidelines

Amlodipine is a medication that must be taken orally (by mouth) and is administered once daily. It is essential to take the dose around the same time every day to maintain consistent blood levels. The medication can be taken with or without food.


Dosing and Regimen

Population Initial Dose (Once Daily) Maximum Dose (Once Daily)
Adults (Standard) 5 mg 10 mg
Elderly / Hepatic Impairment 2.5 mg 10 mg
Pediatric (6–17 years) 2.5 mg 5 mg

Dosage adjustments, if needed, should generally be made after a minimum of 7 to 14 days to allow for the full effect of the previous dose to be reached. For patients with liver (hepatic) impairment, the starting dose is lower (2.5 mg) due to the body's altered processing of the drug.


Procedural Instructions

  1. Preparation: Swallow tablets whole with water. If using an oral solution or suspension, follow label instructions to shake well and use a calibrated measuring device to ensure the correct dose is taken.
  2. Missed Dose: If a dose is missed, take it as soon as possible. However, if it is less than 12 hours before the next scheduled dose, the missed dose should be skipped, and the regular dosing schedule should be resumed. Do not take two doses to make up for a missed one.

Safety and effectiveness of Amlodipine have not been established in children under 6 years of age.

Recent Clinical Evidence

Amlodipin Bluefish: Recent Clinical Evidence

Clinical research has extensively evaluated the role of amlodipine, the active substance in Amlodipin Bluefish, primarily in the management of hypertension (high blood pressure) and chronic stable angina (chest pain).


Efficacy in Blood Pressure and Angina

Clinical trials have demonstrated that amlodipine, as a calcium channel blocker, is associated with a reduction in both systolic and diastolic blood pressure. Its long half-life supports once-daily dosing, with studies showing antihypertensive effectiveness maintained for at least 24 hours. Research has also explored its use as an initial treatment option for hypertension.

For angina, clinical studies have investigated amlodipine's use both as a single therapy and in combination with other antianginal medicines. Findings suggest that it may be associated with increased total exercise time and reduced frequency of anginal attacks in patients with chronic stable angina.


Safety and Tolerability Profile

Safety data collected across multiple clinical settings indicate that the most common reported adverse events typically include peripheral edema (swelling of the ankles or feet), headache, dizziness, and flushing. These events are generally dose-dependent, with a higher incidence observed at the maximum daily dose (10 mg).

Research regarding its use in specific populations has noted that patients with impaired liver function may experience a prolonged half-life of the substance. Caution is indicated when prescribing to individuals with severe hepatic impairment, often requiring a lower starting dose.

Studies have also explored its safety when co-administered with other treatments for hypertension and cardiovascular conditions, such as beta-blockers and ACE inhibitors, generally showing no adverse effects on key heart function parameters.

Frequently Asked Questions (FAQ)

Common questions about Amlodipin Bluefish (FAQ)


Q: How quickly does Amlodipin Bluefish start to lower blood pressure?

A: Amlodipine achieves its highest concentration in the bloodstream approximately 6 to 12 hours after taking an oral dose. However, a minimum period of 7 to 14 days is often allowed for the full blood pressure effect of a dosage change to be reached.

Q: How long does the effect of one Amlodipin Bluefish tablet last?

A: Amlodipine has a long duration of action due to its long half-life, which can be between 30 and 50 hours. This sustained activity is what allows Amlodipin Bluefish to be taken once daily while maintaining its therapeutic effect for at least 24 hours.

Q: Can Amlodipin Bluefish interact with common pain relievers like ibuprofen?

A: Official drug labeling does not specifically list common over-the-counter pain relievers like ibuprofen as established interactions. However, Amlodipin Bluefish is known to have an additive hypotensive effect, which means it may enhance the blood pressure-lowering effect when combined with any other blood pressure-reducing agents.

Q: What kind of medical monitoring is needed while taking Amlodipin Bluefish?

A: Regulatory guidelines suggest blood pressure may need to be checked regularly to determine the medication's response. Official product information notes that patients with certain conditions, such as hepatic impairment or severe heart failure, may require more careful monitoring.

Q: How should Amlodipin Bluefish be stored?

A: Regulatory information states that Amlodipin Bluefish does not require special storage conditions. To maintain its stability, it must be kept in its original container and, as with all medicines, must be kept strictly out of the sight and reach of children.

Q: What if I experience persistent coughing while taking Amlodipin Bluefish?

A: Coughing is listed in official documents as an uncommon adverse reaction associated with amlodipine use, documented during clinical use and post-marketing experience. It is not listed among the most common side effects.

Q: What is the difference between Amlodipin Bluefish and other amlodipine tablets?

A: Amlodipin Bluefish contains the active ingredient Amlodipine. Different brands of amlodipine contain the same active ingredient. However, they may vary in their inactive components, known as excipients, and the specific manufacturer (Bluefish Pharmaceuticals in this case).

Q: Does Amlodipin Bluefish cause weight gain or loss?

A: Official adverse reaction reports indicate that both increases in weight and decreases in weight have been documented as uncommon side effects associated with amlodipine use.

Q: Can Amlodipin Bluefish affect sleep?

A: Yes, official labeling lists effects on the central nervous system. Somnolence (drowsiness) is noted as a common adverse reaction, while insomnia (difficulty sleeping) is listed as an uncommon psychiatric reaction.

Q: Is it normal to feel dizzy when first starting Amlodipin Bluefish?

A: Dizziness is a common side effect documented with Amlodipin Bluefish. Official regulatory documents specifically note that adverse reactions like dizziness and somnolence tend to be more frequent during the initial period of treatment.

Q: Is it safe to take Amlodipin Bluefish with supplements like magnesium or potassium?

A: Official regulatory documents define specific drug-to-drug interactions. However, there are no established regulatory warnings or contraindications regarding co-administration with mineral supplements like magnesium or potassium.

Q: Does Amlodipin Bluefish make you tired?

A: Yes, regulatory documents list general fatigue and asthenia (physical weakness or lack of energy) as common adverse reactions associated with the use of amlodipine.

Q: Does the 'Bluefish' part of the name mean anything important?

A: The 'Bluefish' part of the name refers to the specific company, Bluefish Pharmaceuticals, that manufactures and sells this product containing the active ingredient amlodipine.

Q: Are there any long-term side effects associated with Amlodipin Bluefish use?

A: Official information lists all observed adverse reactions by frequency, including rare and very rare events (such as pancreatitis or hepatic issues) which have been documented over the course of treatment. The list is not specifically separated into short-term versus long-term categories.

Q: Does Amlodipin Bluefish work better if taken in the morning or at night?

A: Amlodipine is highly effective when taken once daily. Official guidelines emphasize taking the dose around the same time every day for consistent blood levels but do not specify whether morning or night is superior for efficacy.

Q: What are the signs of a serious, but rare, side effect from Amlodipin Bluefish?

A: Very rare, serious side effects documented include signs of allergic reactions, such as swelling of the face, lips, or tongue. Regulatory warnings also note the possibility of worsening angina or acute myocardial infarction when initiating therapy or increasing the dose. Symptoms of overdose are described in the official product information.

Q: Can Amlodipin Bluefish affect heart rate?

A: Yes, official adverse reaction data reports that palpitations (a sensation of an irregular or fast heartbeat) are a common side effect. Arrhythmia, including bradycardia (slow heart rate) and tachycardia (fast heart rate), are listed as uncommon reactions.

Q: Are there any studies on Amlodipin Bluefish for preventing strokes?

A: Clinical studies show that the use of amlodipine for lowering high blood pressure is associated with a reduction in the risk of fatal and nonfatal cardiovascular events, including strokes and heart attacks.

Q: Why do doctors prescribe Amlodipin Bluefish for heart conditions?

A: Amlodipine is officially approved for managing high blood pressure (hypertension) and for treating specific types of chest pain (angina). It works by relaxing blood vessels, which reduces the overall workload on the heart.

Q: Are there any dietary restrictions other than grapefruit when taking Amlodipin Bluefish?

A: Official drug interaction labeling specifically warns about consuming grapefruit or grapefruit juice, as this can increase the concentration of amlodipine in the blood. Alcohol is also noted to have an additive blood pressure-lowering effect. No other general food or major dietary restrictions are officially listed.

Q: Do generic versions of amlodipine work the same as Amlodipin Bluefish?

A: Regulatory agencies require that generic products containing the active ingredient amlodipine be proven bioequivalent to the reference product. This means the products must achieve the same concentration in the body at the same time.

Q: Can Amlodipin Bluefish cause skin rashes or itching?

A: Yes, skin conditions are listed as possible side effects. Rash (exanthema) and pruritus (itching) are documented as uncommon adverse reactions. More serious skin reactions, such as angioedema, are listed as very rare.

Q: Is it normal for my blood pressure to still be high a few days after starting Amlodipin Bluefish?

A: It can take time to see the full effect of the medication. Official guidelines state that any adjustment to the dose is typically made after a minimum of 7 to 14 days, as this time is needed for the full blood pressure effect of the current dose to be reached.

Q: Is Amlodipin Bluefish used to treat heart failure?

A: Amlodipine is not officially indicated as a primary treatment for heart failure. Official documents advise caution when prescribing it to patients with severe heart failure (NYHA Class III and IV) due to findings of a potentially increased incidence of pulmonary oedema in one study.

Q: What are the typical expected benefits of taking Amlodipin Bluefish?

A: The main expected benefits, as listed in the official indications, are the effective management of high blood pressure and a reduction in the frequency and severity of certain types of chest pain (angina).

Q: Does Amlodipin Bluefish affect blood sugar levels?

A: Official documents list that hyperglycaemia (an increase in blood sugar levels) has been documented as a very rare adverse reaction associated with the use of amlodipine.

Q: Can Amlodipin Bluefish cause headaches?

A: Yes, headache is a common adverse reaction associated with amlodipine. Official information indicates that headaches are often more frequent during the beginning phase of treatment.

Q: Are there research trials on Amlodipin Bluefish for pediatric use?

A: Official product information confirms that the safety and effectiveness of amlodipine have been established and approved for treating high blood pressure (hypertension) in pediatric patients aged 6 to 17 years.

Q: Can taking Amlodipin Bluefish cause leg cramps?

A: Yes, muscle cramps are listed as a common adverse reaction documented in official regulatory documents related to the use of amlodipine.

Q: Is Amlodipin Bluefish safe during pregnancy or breastfeeding?

A: Official information states that the medicine is not recommended during pregnancy or breastfeeding. The drug may pass into breast milk. Official labeling recommends use only when the potential benefit is considered to outweigh the potential risk.

Q: Are there any reports of Amlodipin Bluefish affecting mood?

A: Official adverse reaction data lists mood changes, including anxiety and depression, as uncommon psychiatric side effects. Confusion is listed as a rare reaction.

Q: Does Amlodipin Bluefish affect sexual function?

A: Impotence (erectile dysfunction) in men is listed as an uncommon adverse reaction. Additionally, gynecomastia (breast enlargement in men) is also listed as an uncommon reaction associated with amlodipine use.

How should Amlodipin Bluefish be stored and disposed of?

Amlodipin Bluefish tablets must be stored and handled according to the instructions on the official product label.

Storage Conditions

No special storage conditions are required for this medicine, and specific temperature limits are not defined in the Summary of Product Characteristics (SmPC). To maintain stability, the tablets must not be used after the expiry date (EXP) printed on the packaging.

Protection and Container Rules

The medicine must always be stored in its original container (blister pack and carton). As a mandatory safety precaution, keep Amlodipin Bluefish tablets out of the sight and reach of children.

Disposal Requirements

Official regulatory guidelines strictly state that the medicine must not be thrown away via wastewater or household waste. There are no special handling requirements for the unused product, but users must ask a pharmacist how to dispose of any medicines that are no longer needed.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Amlodipin Bluefish found in:

A-Z Index: